Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors
Shares of Bristol Myers Squibb Co. BMY shed 3.04% to $58.76 Tuesday, on what proved to be an all-around positive trading ...
The Irish Times1mon
Profits slide at main Irish unit of drug giant Bristol Myers Squibb
Profits slumped 42 per cent at the main Irish unit of pharma giant Bristol Myers Squibb (BMS ... new biologics sterile product facility at its Cruiserath campus in Mulhuddart — the company ...
Buy Rating for Bristol-Myers Squibb Driven by Cobenfy’s Strong Sales Momentum and Growth Potential
Leerink Partners analyst David Risinger has reiterated their bullish stance on BMY stock, giving a Buy rating on January 12.Invest with ...